Health

T-cells from common colds can provide protection against COVID-19: Study

High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.

Read the latest updates in our dedicated coronavirus section.

Immunity against COVID-19 is a complex picture, and while there is evidence of waning antibody levels six months after vaccination, T-cells are also believed to play a vital role in providing protection.

The study, which began in September 2020, looked at levels of cross-reactive T-cells generated by previous common colds in 52 household contacts of positive COVID-19 cases shortly after exposure, to see if they went on to develop infection.

It found that the 26 who did not develop infection had significantly higher levels of those T-cells than people who did get infected. Imperial did not say how long protection from the T-cells would last.

“We found that high levels of pre-existing T cells, created by the body when infected with other human coronaviruses like the common cold, can protect against COVID-19 infection,” study author Dr. Rhia Kundu said.

The authors of the study, published in Nature Communications, said that the internal proteins of the SARS-CoV-2 virus which are targeted by the T-cells could offer an alternative target for vaccine makers.

Current COVID-19 vaccines target the spike protein, which mutates regularly, creating variants such as omicron which lessen the efficacy of vaccines against symptomatic infection.

“In contrast, the internal proteins targeted by the protective T-cells we identified mutate much less,” Professor Ajit Lalvani, co-author of the study, said.

“Consequently, they are highly conserved between the various SARS-CoV-2 variants, including omicron. New vaccines that include these conserved, internal proteins would therefore induce broadly protective T cell responses that should protect against current and future SARS-CoV-2 variants.”

Britain seeks help from private health firms as omicron wave looms

Overwhelmed by omicron surge, US hospitals delay elective surgeries

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.